PMC:7307149 / 20696-20991
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T138 | 86-94 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T139 | 158-164 | Body_part | denotes | serine | http://purl.org/sig/ont/fma/fma82764 |
| T140 | 202-210 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T141 | 238-242 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T92 | 215-223 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T210 | 238-242 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T113 | 86-94 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T114 | 102-113 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
| T115 | 158-164 | Chemical | denotes | serine | http://purl.obolibrary.org/obo/CHEBI_17822 |
| T116 | 202-210 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 371 | 102-133 | Gene | denotes | angiotensin converting enzyme 2 | Gene:59272 |
| 372 | 135-139 | Gene | denotes | ACE2 | Gene:59272 |
| 373 | 144-175 | Gene | denotes | transmembrane serine protease 2 | Gene:7113 |
| 374 | 177-184 | Gene | denotes | TMPRSS2 | Gene:7113 |
| 378 | 215-225 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T111 | 0-295 | Sentence | denotes | We also did not address the potential for individual-level genetic variation in other proteins (e.g., angiotensin converting enzyme 2 [ACE2] or transmembrane serine protease 2 [TMPRSS2], essential host proteins for SARS-CoV-2 priming and cell entry [66]) to modulate the host-pathogen interface. |